Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

SIMPLE SUMMARY: The current study investigated the potential use of fluorometric cfDNA quantification as a prognostic biomarker in advanced non-small cell lung cancer (NSCLC) patients treated with an Immune Checkpoint Blockade (ICB). Results showed that a cfDNA cut-off of 0.55 ng/µL before the ICB d...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Javier, Onieva, Juan Luis, Garrido-Barros, María, Cobo-Dols, Manuel, Martínez-Gálvez, Beatriz, García-Pelícano, Ana Isabel, Dubbelman, Jaime, Benítez, José Carlos, Martín, Juan Zafra, Cantero, Alejandra, Pérez-Ruiz, Elisabeth, Rueda-Domínguez, Antonio, Barragán, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341133/
https://www.ncbi.nlm.nih.gov/pubmed/37444467
http://dx.doi.org/10.3390/cancers15133357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341133/
https://www.ncbi.nlm.nih.gov/pubmed/37444467
http://dx.doi.org/10.3390/cancers15133357

Ejemplares similares